Hand, foot, and mouth disease (HFMD) has become a major public health problem across the Asia-Pacific region, and is commonly caused by Enterovirus A, including enterovirus A71 (EV-A71) and coxsackievirus A (CV-A) 6, 10, and 16. The ability to generate pathogen whole-genome sequences is essential for understanding their genetic diversity and phylodynamics. The frequent replacements among serotypes of Enterovirus A and a limited number of whole-genome sequences available in GenBank hinder the development of overlapping PCRs for whole-genome sequencing. We developed and evaluated a viral specific random PCR (rPCR) and next generation sequencing based assay for sequence independent whole-genome amplification and sequencing of HFMD pathogens. A total of 14 EV-A71/CV-A6/CV-A10/CV-A16 PCR positive rectal/throat swabs (Cp values: 20.9--33.3) were used for assay evaluation. Our assay evidently outperformed the normal rPCR in terms of the total number of EV-A71 reads and the percentage of EV-A71 reads: 3% (3,055/105,000 reads) vs. 0.1% (113/148,000) and 6% (4973/81,000) vs. 0.91% (1,054/116,000) for the samples with Cp values of 30 and 26, respectively. In addition, the assay could generate genome sequences with the percentages of coverage of 94--100% of 4 different HFMD causing enteroviruses in 73% of the tested rectal/throat swabs, representing the first whole-genome sequences of CV-A6/10/16 from Vietnam, and could assign correct serotyping results in 100% of the tested specimens. In all but one the obtained consensuses of two replicates from the same sample were 100% identical, suggesting that our assay is highly reproducible. Phylogenetic analysis of the obtained sequences in the present study suggested that the EV-A71 strains sampled in 2012 belonged to subgenogroup C4, whereas the viruses collected in 2013 belonged to subgenogroup B5. All CV-A16 sequences belonged to genogroup B1a, and showed a close relatedness to the viruses circulating in the Asia-Pacific region. In contrast, the CV-A6 and CV-A10 strains were closely related to the corresponding HFMD-causing viruses from various parts of the world including Europe and Asia. We have successfully developed a viral specific rPCR and next-generation sequencing based assay for sensitive detection and direct whole-genome sequencing of HFMD pathogens from clinical samples.
